Home/HanchorBio/Wenwu Zhai, MD, PhD
WZ

Wenwu Zhai, MD, PhD

Chief Scientific Officer (CSO) / R&D General Manager

HanchorBio

Therapeutic Areas

HanchorBio Pipeline

DrugIndicationPhase
HCB101Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLCPhase 1b/2a
HCB301Solid Tumors, Hematologic MalignanciesPhase 1
HCB303Solid Tumors, Hematologic MalignanciesPreclinical
HCB206Autoimmune DiseasesPreclinical